Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pigmentation Disorder”

822 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 822 results

Not applicableStudy completedNCT03040089
What this trial is testing

Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm

Who this might be right for
Melasma
CynosureLutronic 40
Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT00467831
What this trial is testing

Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

Who this might be right for
Hermansky-Pudlak Syndrome (HPS)Pulmonary FibrosisOculocutaneous Albinism+2 more
National Human Genome Research Institute (NHGRI) 3
Not applicableNot Yet RecruitingNCT07060157
What this trial is testing

Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study

Who this might be right for
Melasma
Assiut University 41
Not applicableStudy completedNCT02368340
What this trial is testing

A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Who this might be right for
Hermansky Pudlak Syndrome
Vanderbilt University 55
Post-approval studies (Phase 4)Study completedNCT04761341
What this trial is testing

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 28
Not applicableEnded earlyNCT01259986
What this trial is testing

Treatment of Vitiligo With Low-energy Visible Light Laser

Who this might be right for
Vitiligo
Henry Ford Health System 3
Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Not applicableStudy completedNCT04460365
What this trial is testing

European Nutrition in Glaucoma Management Trial

Who this might be right for
Glaucoma, Open-Angle
Centre for Eye Research Ireland 64
Not applicableStudy completedNCT02464956
What this trial is testing

Production of iPSC Derived RPE Cells for Transplantation in AMD

Who this might be right for
Age Related Macular Degeneration (AMD)
Moorfields Eye Hospital NHS Foundation Trust 3
Post-approval studies (Phase 4)Study completedNCT00469183
What this trial is testing

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Who this might be right for
Melasma
Galderma R&D 70
Post-approval studies (Phase 4)Study completedNCT02138539
What this trial is testing

Evaluation of an Herbal-Based De-Pigmenting System

Who this might be right for
MelasmaHyperpigmentation
Sadick Research Group 28
Not applicableUnknownNCT01123694
What this trial is testing

Xeroderma Pigmentosum Patient Experiences

Who this might be right for
Xeroderma Pigmentosum
Henry Ford Health System 15
Testing effectiveness (Phase 2)Study completedNCT04927975
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

Who this might be right for
Non-Segmental Vitiligo
AbbVie 185
Not applicableUnknownNCT06189105
What this trial is testing

Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled Trial

Who this might be right for
Skin HyperpigmentationDry Skin; Eczema
University of Split, School of Medicine 25
Post-approval studies (Phase 4)UnknownNCT01661556
What this trial is testing

Clinical Trial of Hydroquinone Versus Miconazol in Melasma

Who this might be right for
Melasma
Universidad Autonoma de San Luis Potosí 60
Not applicableUnknownNCT05252741
What this trial is testing

Levels of Pigment Epithelium-derived Factor in Patients With Psoriasis.

Who this might be right for
Psoriasis
Sohag University 52
Not applicableEnded earlyNCT00047554
What this trial is testing

Study of TRAVATAN in Subjects With Iris Pigmentation Changes

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 336
Load More Results